Literature DB >> 29966706

Sclerosing Cholangitis-Like Changes on Magnetic Resonance Cholangiography in Patients With Drug Induced Liver Injury.

Jawad Ahmad1, Simona Rossi2, Shuchi K Rodgers2, Marwan Ghabril2, Robert J Fontana2, Andrew Stolz2, Paul H Hayashi2, Huiman Barnhart2, David E Kleiner2, Einar S Bjornsson2.   

Abstract

Drug-induced liver injury can lead to changes of the biliary tree that resemble sclerosing cholangitis. These changes can be seen on magnetic resonance cholangiopancreatography. Idiosyncratic drug-induced liver injury (DILI) has a variable presentation including cholestatic liver injury,1 in which case magnetic resonance imaging (MRI) is often performed to exclude pancreaticobiliary causes of obstruction. Sclerosing cholangitis (SC)-like changes on imaging have been described anecdotally with DILI.2,3 A recent study of 25 consecutive, unselected DILI patients found that 10% had SC-like changes on magnetic resonance cholangiopancreatography (MRCP).4 The aim of the current study was to identify the clinical features of patients enrolled in the U.S. Drug Induced Liver Injury Network (DILIN) prospective study who had SC-like changes on MRCP.
Copyright © 2019 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29966706      PMCID: PMC6311440          DOI: 10.1016/j.cgh.2018.06.035

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  8 in total

1.  Docetaxel Induced Sclerosing Cholangitis.

Authors:  Jennifer L Horsley-Silva; Elizabeth N Dow; Christine O Menias; Maxwell L Smith; Estrella M Carballido; Keith D Lindor; Hugo E Vargas
Journal:  Dig Dis Sci       Date:  2015-12       Impact factor: 3.199

2.  Idiosyncratic drug-induced liver injury is associated with substantial morbidity and mortality within 6 months from onset.

Authors:  Robert J Fontana; Paul H Hayashi; Jiezhun Gu; K Rajender Reddy; Huiman Barnhart; Paul B Watkins; Jose Serrano; William M Lee; Naga Chalasani; Andrew Stolz; Timothy Davern; Jayant A Talwakar
Journal:  Gastroenterology       Date:  2014-03-27       Impact factor: 22.682

3.  Secondary sclerosing cholangitis in patients with drug-induced liver injury.

Authors:  Hafsteinn O Gudnason; Helgi K Björnsson; Marianna Gardarsdottir; Hjalti M Thorisson; Sigurdur Olafsson; Ottar M Bergmann; Einar S Björnsson
Journal:  Dig Liver Dis       Date:  2015-03-11       Impact factor: 4.088

Review 4.  Risk factors for idiosyncratic drug-induced liver injury.

Authors:  Naga Chalasani; Einar Björnsson
Journal:  Gastroenterology       Date:  2010-04-12       Impact factor: 22.682

5.  ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries.

Authors:  Paul Y Kwo; Stanley M Cohen; Joseph K Lim
Journal:  Am J Gastroenterol       Date:  2016-12-20       Impact factor: 10.864

6.  Chemotherapy-induced sclerosing cholangitis.

Authors:  K Sandrasegaran; W M Alazmi; M Tann; E L Fogel; L McHenry; G A Lehman
Journal:  Clin Radiol       Date:  2006-08       Impact factor: 2.350

7.  Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study.

Authors:  Naga Chalasani; Herbert L Bonkovsky; Robert Fontana; William Lee; Andrew Stolz; Jayant Talwalkar; K Rajendar Reddy; Paul B Watkins; Victor Navarro; Huiman Barnhart; Jiezhun Gu; Jose Serrano
Journal:  Gastroenterology       Date:  2015-03-06       Impact factor: 22.682

8.  Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct.

Authors:  Robert J Fontana; Paul B Watkins; Herbert L Bonkovsky; Naga Chalasani; Timothy Davern; Jose Serrano; James Rochon
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

  8 in total
  6 in total

1.  Bile Duct Injury due to Drug Induced Liver Injury.

Authors:  Priya Grewal; Jawad Ahmad
Journal:  Curr Hepatol Rep       Date:  2019-07-15

Review 2.  Drug-Induced Liver Injury: Highlights of the Recent Literature.

Authors:  Mark Real; Michele S Barnhill; Cory Higley; Jessica Rosenberg; James H Lewis
Journal:  Drug Saf       Date:  2019-03       Impact factor: 5.606

Review 3.  Drug-Induced Liver Injury: Highlights and Controversies in the Recent Literature.

Authors:  Joseph William Clinton; Sara Kiparizoska; Soorya Aggarwal; Stephanie Woo; William Davis; James H Lewis
Journal:  Drug Saf       Date:  2021-09-17       Impact factor: 5.606

4.  Checkpoint inhibitor-induced hepatotoxicity: Role of liver biopsy and management approach.

Authors:  Fernando Bessone; Einar Stefan Bjornsson
Journal:  World J Hepatol       Date:  2022-07-27

5.  Long-Term Outcomes After Drug-Induced Liver Injury.

Authors:  Paul H Hayashi; Einar S Bjornsson
Journal:  Curr Hepatol Rep       Date:  2018-07-02

6.  Ketamine-Induced Sclerosing Cholangitis (KISC) in a Critically Ill Patient With COVID-19.

Authors:  Sally A I Knooihuizen; Ariel Aday; William M Lee
Journal:  Hepatology       Date:  2021-05-28       Impact factor: 17.298

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.